Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
europe
2
×
barcelona
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe blog main
europe top stories
fda
impress
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
orthodontics
orthodontist
slgt2 inhibitor
tc
type 1 diabetes
type 2 diabetes
What
bid
2
×
access
alignment
aping
approval
area
barcelona
barcelona’s
based
boehringer
clinics
consumers
conventional
cosmetic
covered
diabetes
digitalized
digitize
drug
eli
expand
fallen
fda
heads
impress
ingelheim
involves
lilly
marketed
medical
medicine’s
million
new
orthodontic
orthodontics
patients
process
raising
rejects
round
Language
unset
Current search:
bid
×
europe
×
@techcrunch.com
1 year ago
Barcelona’s Impress heads towards a $125M Series B round in its bid to digitize orthodontics
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
